Open
Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
National Institutes of Health·Government
AI Summary
The National Institutes of Health seeks proposals for the advanced development and validation of emerging technologies for basic and clinical cancer research. This opportunity is not open to clinical trials. The goal is to support innovative technologies that can be used to investigate cancer biology and improve cancer treatment outcomes.
Full Description
Title: Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
Agency: National Institutes of Health
Agency Code: HHS-NIH11
Status: posted
Document Type: synopsis
Open Date: 06/03/2026
Close Date: 11/10/2026
CFDA Numbers: 93.394
Opportunity Number: RFA-CA-27-002
Opportunity ID: 360534